Table 2:

Possible clinical outcome predictors for interlaminar ESI at short-term follow-up^a

	Improvement (n = 63)	No Improvement (n = 18)	P Value
Ageb	50 ± 13.5	49.6 ± 17.6	.914
Sex
Male	10 (62.5%)	6 (37.5%)	.175
Female	53 (81.5%)	12 (18.5%)
Duration of LBP
<3 Months	32 (78.0%)	9 (22.0%)	1.000
>3 months	31 (77.5%)	9 (22.5%)

^aData are number of patients.

^bMean age (years).